LivingGLP1
Study S002627

Evaluating the Efficacy of High-Protein Diabetes Specific Formula (HP-DSF) on Body Composition in Overweight/Obese Patients With Type 2 Diabetes Treated With Incretin Mimetic Drugs

Registration

Registration
NCT07271043
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
RECRUITING
Enrollment
60
Start
2026-01-01
Primary completion
2026-11-01
Lead sponsor
Joslin Diabetes Center
Conditions
Type 2 Diabetes
Interventions
DIETARY_SUPPLEMENT:protein supplement
Results posted
FALSE
Individual participant data sharing
UNDECIDED

Registered primary outcomes

  • Change in lean muscle mass from baseline [Endpoints will be analyzed at three months and six months.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.